630. Emergence of Colistin Resistance in the OVERCOME Trial: Impact of Combination Therapy with Meropenem

BACKGROUND: Colistin (COL) remains an important therapeutic option for carbapenem-resistant (CR) Gram-negative bacilli (GNB). COL is often utilized in combination with meropenem (MEM), in part due to concerns regarding the development of COL resistance with monotherapy. We recently completed a rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogue, Jason M, Rybak, Michael J, Stamper, Kyle, Marchaim, Dror, Thamlikitkul, Visanu, Carmeli, Yehuda, Chiu, Cheng, Daikos, Georgios L, Dhar, Sorabh, Mangoni, Emanuele Durante, Gikas, Achilleas, Kotanidou, Anastasia, Paul, Mical, Roilides, Emmanuel, Samarkos, Michael, Sims, Matthew, Tancheva, Dora, Tsiodras, Sotirios, Divine, George, Ghazaryan, Varduhi, Kaye, Keith S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644241/
http://dx.doi.org/10.1093/ofid/ofab466.828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644241/
http://dx.doi.org/10.1093/ofid/ofab466.828

Ejemplares similares